linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 386.60
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 958030.06
P/E 56.24
EPS 41.27
Face Value 1  
14-Apr-2026 Mankind Pharma informs about updates
18-Mar-2026 Mankind Pharma acquires ‘Rivotril’ brand from Roc...
18-Mar-2026 Mankind Pharm informs about press release
18-Mar-2026 Mankind Pharma surges on acquiring ‘Rivotril’ bra...
27-Feb-2026 Clarification sought from Mankind Pharma Ltd
03-Feb-2026 Mankind Pharm reports 8% rise in Q3 consolidated ...
13-Nov-2025 Mankind Pharma submits analyst meet intimation
07-Nov-2025 Mankind Pharma reports 21% fall in Q2 consolidate...
29-Oct-2025 Mankind Pharma informs about earnings call
13-Oct-2025 Mankind Pharma inks pact to acquire Women Health ...
08-Sep-2025 Mankind rises on getting CDSCO’s approval for Pha...
20-Aug-2025 Mankind Pharma inches up on incorporating wholly ...
19-Aug-2025 Mankind Pharma incorporates wholly owned subsidia...
01-Aug-2025 Mankind Pharma reports 18% fall in Q1 consolidate...
01-Aug-2025 Mankind Pharma trades in green despite reporting ...
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.